Inivata Raises £31.5M in Series A Financing Round | GenomeWeb

NEW YORK (GenomeWeb) – Cancer liquid biopsy company Inivata of Cambridge, UK, has raised £31.5 million ($45 million) in a Series A financing round, the firm said today.

Existing investors Imperial Innovations, Cambridge Innovation Capital, and Johnson & Johnson Innovation – JJDC, and new investor Woodford Patient Capital Trust participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.